ENVALITH
栄研化学株式会社 logo

EIKEN CHEMICAL CO.,LTD.

4549Prime MarketPharmaceuticals

栄研化学株式会社 logo
EIKEN CHEMICAL CO.,LTD.4549
Reference Indicators

Market Cap

890¥100M

P/E (Forecast)

P/B

1.9x

Dividend Yield (Forecast)

2.25%

ROE

8.5%

EV/EBITDA

15.4x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
42,99643,27140,05240,53941,899
Cost of Sales
22,43122,76523,32824,02725,723
Gross Profit
20,56420,50616,72316,51216,175
SG&A Expenses
12,18413,04913,34513,51213,255
Operating Income
8,3877,4573,3772,9992,919
Non-operating Income
164154284235164
Non-operating Expenses
43429336239
Ordinary Income
8,5087,5683,5683,1982,844
Extraordinary Income
1811492,013
Extraordinary Losses
27576625622
Pre-tax Income
8,4827,5923,5032,9914,834
Income Taxes
2,2631,8568697631,125
Net Income
6,2185,7362,6342,2283,708
EBITDA
10,4459,5825,7035,5535,455
Gross Margin
47.8%47.4%41.8%40.7%38.6%
Operating Margin
19.5%17.2%8.4%7.4%7.0%
ROA
9.9%8.7%4.3%3.6%5.9%
ROE
14.3%12.1%5.6%5.0%8.5%